Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-24-057455)

Filing Details

Accession Number:: 0000950170-24-057455
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-05-10 07:30:17
Reporting Period:: 2024-05-08

Accepted Time:: 2024-05-10 07:30:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1095981	Plus Therapeutics Inc.	PSTV	Surgical & Medical Instruments & Apparatus (3841)	330827593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1203672	H Marc Hedrick	C/O Plus Therapeutics Inc. 4200 Marathon Boulevard, Suite 200 Austin TX 78756	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-05-08	12,255	$2.04	12,425	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock Warrants	Warrants (Right to buy)	Acquisiton	2024-05-08	24,510	$0.00	24,510	$1.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,510	2024-05-08		No	4	A	Direct

Footnotes

The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.
Half of the warrants are Series A warrants and the other half are Series B warrants.